Literature DB >> 19100517

Deletion 15q as the sole abnormality in acute myeloid leukemia: report of three cases and review of the literature.

Gary Lu1, C Cameron Yin, L Jeffrey Medeiros, Lynne V Abruzzo.   

Abstract

Deletions within the long arm of chromosome 15, a recurrent abnormality in myeloid malignancies, have been reported previously as a sole abnormality in only eight cases of acute myeloid leukemia (AML). We describe three new cases of AML with this abnormality, all adult women (age, 41-66 years). Two cases were acute myelomonocytic leukemia (FAB AML-M4), and one was acute myeloblastic leukemia with maturation (FAB AML-M2). The deletion was identified at initial diagnosis in one patient and at relapse in the other two. Although all received aggressive therapy, their survival was short. Taken together with the eight previously reported cases, we conclude that deletions in chromosome 15 are associated with AML, both in cases that arise de novo or in the setting of a myeloproliferative disorder or myelodysplastic syndrome. These cases often show features of myelomonocytic or monocytic differentiation. The prognosis is poor, with survival similar to other AML cases with unfavorable cytogenetic changes.

Entities:  

Mesh:

Year:  2009        PMID: 19100517     DOI: 10.1016/j.cancergencyto.2008.09.006

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Trisomy 11 as an isolated abnormality in acute myeloid leukemia is associated with unfavorable prognosis but not with an NPM1 or KIT mutation.

Authors:  Faisal M Alseraye; Zhuang Zuo; Carlos Bueso-Ramos; Sa Wang; L Jeffrey Medeiros; Gary Lu
Journal:  Int J Clin Exp Pathol       Date:  2011-04-25

2.  del(15q) is a recurrent minor-route cytogenetic abnormality in the clonal evolution of chronic myelogenous leukemia.

Authors:  C Cameron Yin; Lynne V Abruzzo; Xiaoyan Qiu; Effrosyni Apostolidou; Jorge E Cortes; L Jeffrey Medeiros; Gary Lu
Journal:  Cancer Genet Cytogenet       Date:  2009-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.